211 related articles for article (PubMed ID: 7978895)
1. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival.
Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():46-55. PubMed ID: 7978895
[No Abstract] [Full Text] [Related]
2. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumours: clinical presentation and management of localized disease.
Kulke MH
Cancer Treat Rev; 2003 Oct; 29(5):363-70. PubMed ID: 12972355
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours.
Petersen I
Cell Oncol; 2006; 28(3):117-8; author reply 119-20. PubMed ID: 16823180
[No Abstract] [Full Text] [Related]
5. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of neuroendocrine tumors (including carcinoid).
Doherty G
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):32-6. PubMed ID: 23183358
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal neuroendocrine/neuroectodermal tumors.
Fenoglio-Preiser CM
Am J Clin Pathol; 2001 Jun; 115 Suppl():S79-93. PubMed ID: 11993693
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
[TBL] [Abstract][Full Text] [Related]
10. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
[TBL] [Abstract][Full Text] [Related]
11. Highlights of the biology of endocrine tumours of the gut and pancreas.
Rindi G; Bordi C
Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
[TBL] [Abstract][Full Text] [Related]
12. Resectability of primary gastroenteropancreatic neuroendocrine tumor as a prognostic factor for survival.
Medrano-Guzmán R; López-García SC; Torres-Vargas S; González-Rodríguez D; Alvarado-Cabrero I
Cir Cir; 2011; 79(6):498-504. PubMed ID: 22169366
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary neuroendocrine/carcinoid tumors: a review article.
Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
[TBL] [Abstract][Full Text] [Related]
14. Peptide receptors in gut endocrine tumours.
de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):571-87. PubMed ID: 9113313
[TBL] [Abstract][Full Text] [Related]
15. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
16. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].
Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402
[No Abstract] [Full Text] [Related]
17. Activity of sunitinib in patients with advanced neuroendocrine tumors.
Kulke MH; Lenz HJ; Meropol NJ; Posey J; Ryan DP; Picus J; Bergsland E; Stuart K; Tye L; Huang X; Li JZ; Baum CM; Fuchs CS
J Clin Oncol; 2008 Jul; 26(20):3403-10. PubMed ID: 18612155
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of somatostatin receptor-2 positivitiy in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors.
Yenıay L; Gürcü B; Ünalp Ö; Yilmaz F; Nart D; Sözbılen M; Çoker A
Turk J Gastroenterol; 2012; 23(6):736-40. PubMed ID: 23794313
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
[No Abstract] [Full Text] [Related]
20. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
